NCT06446869 is a NA clinical trial of Gyntima Menopause in Menopause, sponsored by Community Pharmacology Services Ltd.

Who is sponsoring NCT06446869?

NCT06446869 is sponsored by Community Pharmacology Services Ltd.

What drugs are being tested in NCT06446869?

Interventions in NCT06446869: Gyntima Menopause, Placebo.

Is NCT06446869 still recruiting?

NCT06446869 is currently recruiting now. Last updated 26 January 2026.

Last reviewed 2026-01-26 · How we verify

NCT06446869

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Menopausal Symptoms Probiotic Study

Recruiting now NA Last updated 26 January 2026

What this trial tests

NA trial testing Gyntima Menopause in Menopause in 140 participants. Currently enrolling.

Timeline

10 September 2024

Primary endpoint
25 July 2026

25 October 2026

Quick facts

Lead sponsor	Community Pharmacology Services Ltd
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	140
Start date	10 September 2024
Primary completion	25 July 2026
Estimated completion	25 October 2026
Sites	1 location across United Kingdom

Drugs / interventions tested

Gyntima Menopause
Placebo

Conditions studied

Menopause — all drugs for Menopause →

Sponsor

Community Pharmacology Services Ltd

Who can join

Adults 42 to 60, female only, with Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, we want to investigate if the active product consisting of a probiotic blend can potentiate the recirculation of active oestrogens into the bloodstream and help to mitigate menopause symptoms, which are closely related to oestrogens levels

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Menopause

Currently open trials in the same condition.

NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting

Other Community Pharmacology Services Ltd trials

Trials by the same sponsor.

NCT05762432 — Diabetic Foot Ulcer Research Study · NA · recruiting
NCT05903612 — Allergic Bronchopulmonary Aspergillosis Prescreening Study · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06446869 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Community Pharmacology Services Ltd
Last refreshed: 26 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06446869.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing